study found genetic variant for hair graying, susceptibility to skin melanoma in horses
On Sep. 4, 2024, an international consortium led by scientists from Uppsala University in Sweden reported that the…
Biotechnology | Diagnostics | Disease | Life Science News | NIH | Oncology | Radiology | Therapeutics | Women's Health
NCI’s Cancer Trends Progress Report announced 2023 Incidence and Mortality Data
On Sep. 3, 2024, the National Cancer Institute (NCI) announced that the latest Cancer Trends Progress Report included…
Molecular jackhammers’ ‘good vibrations’ eradicate cancer cells
On Dec. 19, 2023, a research team led by Rice University reported they found that the atoms of…
Oregon Health Sciences University dermatologists detected the world’s smallest skin cancer
On May 1, 2023, an Oregon Health Sciences University (OHSU) dermatologist and a multi-disciplinary team confirmed that a…
U.S. Preventive Services Task Force issued recommendation on screening for skin cancer
On Apr. 18, 2023, the U.S. Preventive Services Task Force (USPSTF) published a final recommendation statement on screening…
Rapid decrease in lung cancer and melanoma deaths lead overall continued decline in cancer death rate
On Jul. 8, 2021, the National Institutes of Health (NIH) reported that the overall cancer death rates continue…
AIM ImmunoTech announced NCI award of $14.54 million to study Ampligen as part of five Roswell Park-led chemokine modulation clinical trials in melanoma, colorectal and ovarian cancers
On Apr. 6, 2020, the National Cancer Institute awarded of $14.54 million to Roswell Park Comprehensive Cancer Center…
Biotechnology | Diagnostics | Disease | Life Science News | Non-Profit Research | Oncology | Radiology | Therapeutics
UArizona Cancer Center received $69M grant forsSkin cancer prevention study
On Mar. 19, 2020, The UArizona Cancer Center announced it was awarded a five-year, $6.9 million prestigious Program…
Biotechnology | Diagnostics | Disease | Life Science News | Non-Profit Research | Radiology | Therapeutics
Masonic Cancer Center researcher Dr. Liang Liu received skin cancer research grant
On Mar. 13, 2019, Dr. Liang Lie of Mason Cancer Center’s Hormel Institute received a $100,000 two year…
Genentech drug Cotellic (cobimetinib) was approved
On Nov. 10, 2015, Genentech announed that its drug Cotellic (cobimetinib) was approved by the U.S. Food and…
Genentech medicine approved for certain type of melanoma
On Aug. 17, 2011, Genentech announced that Elborafﾮ (vemurafenib) was approved by the FDA for the treatment of…
Genentech drug Zelboraf (vemurafenib) was approved
On Aug. 16, 2011, the U.S. Food and Drug Administration (FDA) approved vemurafenib tablets (Zelboraf, Hoffmann-LaRoche Inc.) for…
Smilow Cancer Hospital opened for patient care
On Oct. 26, 2009, the Smilow Cancer Hospital opened for patient care with María Rosa Menocal, a Yale…
Yale Cancer Center was awarded a SPORE (Specialized Programs of Research Excellence) grant for translational research
On Oct. 10, 2006, Yale Cancer Center was awarded a SPORE (Specialized Programs of Research Excellence) grant for…
National Cancer Institute researchers developed a new model for estimating the 5-year risk of melanoma
On Sept. 1, 2006, National Cancer Institute (NCI) researchers developed a new model for estimating the 5-year risk…
The National Cancer Institute scientists identified an inherited gene that strongly affects risk for the most common form of melanoma
On Jun. 29, 2006, researchers at the National Cancer Institute have identified a link between inherited and acquired…
National Cancer Institute researchers replace a patient’s immune system with cancer-fighting cells
On Sept. 19, 2002, a new approach to cancer treatment that replaced a patient’s immune system with cancer-fighting…
Dr. Steven A Rosenberg conducted the first human gene transfer trial
On May 22, 1989, Dr. Steven A. Rosenberg and his team at the National Cancer Institute (NCI) performed…
The Cold Spring Harbor Laboratory Cancer Center received NCI designation
In 1987, The Cold Spring Harbor Laboratory (CSHL) Cancer Center received National Cancer Institute (NCI) designation. CSHL researchers…
Interferon became the first anticancer drug produced through biotechnology
On Jun. 5, 1986, the U.S. Food and Drug Administration (FDA) approved Hoffmann La Roche’s Interferon initially for…